Added to YB: 2026-06-08
Pitch date: 2026-06-04
CAI [neutral]
Caris Life Sciences, Inc.
Author Info
The Micro-Capo is a blog where I share news and articles on companies I like or own. Sign up for the newsletter.
Company Info
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
Market Cap
$4.7B
Pitch Price
N/A
Price Target
40.00 (+131%)
Dividend
N/A
EV/EBITDA
30.55
P/E
-9.18
EV/Sales
4.71
Sector
Biotechnology
Category
growth
Monthly Report - Caris Life Sciences, Inc.
CAI (holding update): Caris Life Sciences Q1 2026 rev $216.2M (+79% YoY), 65% gross margin, positive adj EBITDA $26.2M (key catalyst). Refinanced $400M facility w/ Blue Owl & Blackstone. Druckenmiller anchor (1.89M shares, ~$34M). Down 2.5% from $16.68 entry. PT $40, +144% upside.
Read full article (1 min)